NDC 49281-190

IMOGAM RABIES-HT

Human Rabies Virus Immune Globulin

IMOGAM RABIES-HT is a Intramuscular Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Human Rabies Virus Immune Globulin.

Product ID49281-190_53595fe1-05a5-4db7-8f62-4535188ab5ac
NDC49281-190
Product TypePlasma Derivative
Proprietary NameIMOGAM RABIES-HT
Generic NameHuman Rabies Virus Immune Globulin
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date1984-04-27
Marketing CategoryBLA / BLA
Application NumberBLA103932
Labeler NameSanofi Pasteur Inc.
Substance NameHUMAN RABIES VIRUS IMMUNE GLOBULIN
Active Ingredient Strength150 [iU]/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 49281-190-20

1 VIAL, SINGLE-DOSE in 1 CARTON (49281-190-20) > 2 mL in 1 VIAL, SINGLE-DOSE (49281-190-58)
Marketing Start Date1984-04-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49281-190-58 [49281019058]

IMOGAM RABIES-HT INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103932
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2014-11-17

NDC 49281-190-20 [49281019020]

IMOGAM RABIES-HT INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103932
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1984-04-27

Drug Details

Active Ingredients

IngredientStrength
HUMAN RABIES VIRUS IMMUNE GLOBULIN150 [iU]/mL

NDC Crossover Matching brand name "IMOGAM RABIES-HT" or generic name "Human Rabies Virus Immune Globulin"

NDCBrand NameGeneric Name
49281-190IMOGAM RABIES-HTHUMAN RABIES VIRUS IMMUNE GLOBULIN
76125-150KEDRABHUMAN RABIES VIRUS IMMUNE GLOBULIN

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.